Urology · Houston, TX
NPI
1669677381
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6620 Main Street, Suite 1325
Houston, TX, 77030
Phone (713) 798-4001
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
7,384 services
Medicare patients, 2024
512
Average age 73
Drug cost, 2024
$401K
1,746 prescriptions
Company payments, 2025
$64K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohit Khera was code Q9958 (high osmolar contrast material, up to 149 mg/ml iodine concentration, per ml), 4,150 times for 14 patients. In total Mohit Khera billed 7,384 services in 72 codes, and Medicare paid $245K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-20.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | Office | 4,150 | 14 | $0.06 | $256 |
| 84403 Clinical Chemistry | Office | 381 | 239 | $25.29 | $9,635 |
| 84270 Clinical Chemistry | Office | 366 | 228 | $21.30 | $7,796 |
| 82670 Clinical Chemistry | Office | 341 | 207 | $27.26 | $9,295 |
| 84153 Clinical Chemistry | Office | 287 | 182 | $17.91 | $5,140 |
| 99214 Office E&M - Established | Office | 277 | 204 | $90.80 | $25K |
| 99213 Office E&M - Established | Office | 247 | 188 | $68.34 | $17K |
| 11980 Skin | Office | 135 | 55 | $75.38 | $10K |
| J3490 Unclassified drugs | Office | 118 | 52 | $821.31 | $97K |
| 51798 Ultrasound - Nonspecific | Office | 93 | 81 | $7.68 | $714 |
| 99203 Office E&M - New | Office | 92 | 92 | $69.26 | $6,372 |
| 99212 Office E&M - Established | Office | 63 | 51 | $34.03 | $2,144 |
| 52000 Cystourethroscopy | Office | 61 | 52 | $172.59 | $11K |
| 81002 Clinical Chemistry | Office | 44 | 33 | $3.41 | $150 |
| 84154 Clinical Chemistry | Office | 39 | 35 | $17.61 | $687 |
By year: 2022 $323K for 10,481 services; 2023 $299K for 6,838 services; 2024 $245K for 7,384 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84403 Clinical Chemistry | 381 | 239 | $25.29 | $9,635 |
| 84270 Clinical Chemistry | 366 | 228 | $21.30 | $7,796 |
| 82670 Clinical Chemistry | 341 | 207 | $27.26 | $9,295 |
| 84153 Clinical Chemistry | 287 | 182 | $17.91 | $5,140 |
| 81002 Clinical Chemistry | 44 | 33 | $3.41 | $150 |
| 84154 Clinical Chemistry | 39 | 35 | $17.61 | $687 |
| 86316 Immunoassay | 36 | 33 | $19.89 | $716 |
| 81003 Clinical Chemistry | 33 | 32 | $2.20 | $72.6 |
| 82627 Clinical Chemistry | 24 | 23 | $21.79 | $523 |
| 83001 Clinical Chemistry | 21 | 21 | $18.21 | $382 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohit Khera prescribed most often to Medicare patients was Tamsulosin Hcl, with 323 prescriptions and refills. In total Mohit Khera wrote 1,746 Medicare prescriptions that cost $401K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 323 | 920 | 122 | $6,188 |
| Gemtesa Vibegron | 107 | 207 | 33 | $99K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 96 | 261 | 34 | $2,119 |
| Finasteride Generic | 73 | 207 | 24 | $1,150 |
| Testosterone Cypionate Generic | 73 | 124 | 29 | $4,829 |
| Testosterone Enanthate Generic | 68 | 119 | 32 | $5,428 |
| Anastrozole Generic | 63 | 178 | 20 | $338 |
| Levofloxacin Generic | 55 | 55 | 47 | $141 |
| Testosterone Generic | 54 | 96 | 26 | $11K |
| Ciprofloxacin Hcl Generic | 46 | 46 | 32 | $289 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 44 | 120 | 15 | $1,751 |
| Trazodone Hcl Generic | 44 | 87 | 13 | $162 |
| Meloxicam Generic | 41 | 49 | 20 | $132 |
| Solifenacin Succinate Generic | 39 | 114 | 15 | $1,487 |
| Myrbetriq Mirabegron | 39 | 69 | 16 | $31K |
Brand drugs: - claims; generic drugs: 1,506 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohit Khera $64K ($64K in general payments such as food, travel and fees) from 8 companies. The largest payer was Boston Scientific Corporation with $20K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.